Public Health England
82
0
2
64
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
6.1%
5 terminated/withdrawn out of 82 trials
92.8%
+6.3% vs industry average
29%
24 trials in Phase 3/4
9%
6 of 64 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (82)
Transcriptional Responses as an Indicator of Individualised Responses to Radiation Effects (RTGene 2)
Role: collaborator
Breast Screening - Risk Adaptive Imaging for Density
Role: collaborator
A Human Controlled Infection Study with Neisseria Lactamica in Malian Adults
Role: collaborator
Patient Outcomes from Second Film-readers and Test Threshold Relaxation in Breast Screening
Role: collaborator
Screening for HPV and Cervical Cancer in Young Women With Perinatally Acquired HIV
Role: collaborator
Assessment of Viral Shedding Week Following Administration of Live Attenuated Influenza Vaccine in Children
Role: collaborator
Preventing Relapse to Smoking Among Prisoners After Release
Role: collaborator
Maternal Pertussis Wholecell Responses
Role: collaborator
Development of a Serocorrelate of Protection Against Invasive Group B Streptococcus Disease
Role: collaborator
Using Text Messages to Boost COVID-19 Vaccine Booking Rate
Role: collaborator
Predictive Values of Next Generation Interferon Gamma Release Assays for Latent Tuberculosis Infection
Role: collaborator
Childhood Influenza Immunisation Invitation Trial in Schools
Role: lead
Adjunctive Clindamycin for Cellulitis: C4C Trial.
Role: collaborator
Cardiovascular Function and Ribavirin Pharmacokinetics and Pharmacodynamics in Patients With Lassa Fever
Role: collaborator
HPV Vaccination in Africa- New Delivery Schedules Alias The HANDS HPV Vaccine Trial
Role: collaborator
COG-UK Project Hospital-Onset COVID-19 Infections Study
Role: collaborator
Propositive (Protecting Positive People From Meningococcal Infection) Follow-up Study
Role: collaborator
Completion and Acceptability of Treatment Across Primary Care and the commUnity for Latent Tuberculosis
Role: collaborator
Effectiveness and Safety of a Heterologous, Two-dose Ebola Vaccine in the DRC
Role: collaborator
Improving the Behavioural Impact of Air Quality Alerts
Role: collaborator